Selenium Levels in Patients With Abdominal Aneurysm
1 other identifier
observational
40
1 country
1
Brief Summary
Retrospective study comparing the selenium level in patients with abdominal aortic aneurysm with the selenium level in patients in the control group, i.e., patients without aneurysmal changes of the abdominal aorta.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedFirst Submitted
Initial submission to the registry
November 15, 2025
CompletedFirst Posted
Study publicly available on registry
November 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedNovember 19, 2025
November 1, 2025
8 months
November 15, 2025
November 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Odds Ratio
Odds Ratio - odds of having lower than normal selenium levels in cases compared to the same odds in controls
From enrollment to 12 months after enrollment
Study Arms (2)
Cases - persons with abdominal aortic aneurysm
Persons with abdominal aortic aneurysm (AAA) of minimally 35 mm diameter, followed by vascular surgery outpatient office. AAA is verified by radiology, was not treated by surgical or endovascular intervention.
Controls - persons without abdominal aortic aneurysm
Persons without abdominal aortic aneurysm (AAA), as confirmed by ultrasonography. Controls will be recruited from vascular surgery outpatient office, in treatment for other vascular conditions.
Eligibility Criteria
The study group comprises of 40 subjects. Twenty are cases, these are patients with AAA that was confirmed by radiology. The AAA was not treated by surgery or endovascular intervention. The are followed for the AAA by vascular surgery outpatient office. Controls are twenty persons without AAA, as confirmed by ultrasonography. They are followed by vascular surgery outpatient office for other vascular diseases. Both cases and controls are taken a blood sample, in which blood selenium level is established. Odds ratio will be calculated of having low than normal blood selenium levels in cases versus controls.
You may qualify if:
- cases - patients with AAA (confirmed by radiology) followed by vascular surgery outpatient office that signed informed consent. The AAA was not treated by surgery or endovascular intervention
- controls - people without AAA (confirmed by ultrasonography) followed by vascular surgery outpatient office for other vascular disease that signed informed consent
You may not qualify if:
- patients that had AAA treated by surgery or endovascular intervention
- persons that did not sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Comenius Universitylead
- University Hospital Bratislavacollaborator
Study Sites (1)
University Hospital Bratislava
Bratislava, 85107, Slovakia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair of Institute of Epidemiology, Faculty of Medicine
Study Record Dates
First Submitted
November 15, 2025
First Posted
November 19, 2025
Study Start
January 15, 2025
Primary Completion
September 15, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share